Next Article in Journal
Evaluation of Specific Cellular and Humoral Immune Response to Toxoplasma gondii in Patients with Autoimmune Rheumatic Diseases Immunomodulated Due to the Use of TNF Blockers
Previous Article in Journal
Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
Previous Article in Special Issue
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?
 
 
Review
Peer-Review Record

Mechanisms of COVID-19 Associated Pulmonary Thrombosis: A Narrative Review

Biomedicines 2023, 11(3), 929; https://doi.org/10.3390/biomedicines11030929
by Cristian-Mihail Niculae 1,2,*, Adriana Hristea 1,2 and Ruxandra Moroti 1,2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomedicines 2023, 11(3), 929; https://doi.org/10.3390/biomedicines11030929
Submission received: 28 February 2023 / Revised: 13 March 2023 / Accepted: 15 March 2023 / Published: 16 March 2023
(This article belongs to the Special Issue Non-antiviral Agents for Treatment of COVID-19 2.0)

Round 1

Reviewer 1 Report

the manuscript is interesting, generally well written and well illustrated. Only minor comments are necessary. In particular: 

Introduction: it deserves to be mentioned that SARS-CoV-2 can also lead to non restiratory diseases such as Preeclampsia, male infertility and brain damage (as recently reviewed PMID: 35114008, 35943095, 32934351). This is an important point to add since it highlights the fact that the cytokine storm found in COVID-19 patients can also damage other organs.

A table summarizing the studies discussed in the manuscript should be added.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

The Romanian authors summarized the current knowledge on the pathomechanisms of pulmonary thrombosis in the course of COVID-19. Although this clinical problem is widely known, the narrative review by Dr. Cristian-Mihail Niculae and colleagues is meticulous and describes in detail the individual elements leading to blood clotting disorders in COVID-19.

The paper lacks data that TEG and ROTEM provide in severe COVID-19. Authors, e.g., as the final subsection of a manuscript, may raise this issue using the following publications:

doi: 10.1055/a-1346-3178.

doi: 10.3390/life12101658.

doi: 10.3390/ijms24054319

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

The authors have addressed all my concerns. 

Back to TopTop